Cyprotex have expertise in in vitro metabolism, in vitro permeability, transporters, solubility and physicochemical properties, in vitro protein binding and PK and bioanalysis.
Read moreCyprotex use a range of HCS, MEA and biochemical endpoints to identify potential for genotoxicity, hepatotoxicity, cardiotoxicity, neurotoxicity and nephrotoxicity.
Read moreCyprotex specializes in 2D and 3D phenotypic cell-based models using a range of different techniques such as HCS, microelectrode array, cellular bioenergetics and RT-PCR.
Read moreCyprotex are highly experienced in QSAR and PBPK techniques, and we have developed our own proprietary software tools for accurately predicting pharmacokinetics.
Read moreCyprotex is now part of Evotec, enabling us to offer integrated and standalone drug discovery services.
Read more
Cyprotex offer a comprehensive panel of ADME, toxicity and bioscience services for testing potential new pharmaceuticals.
Read moreCyprotex provide in vitro genotoxicity and phototoxicity screening methods for testing personal care and cosmetic formulations.
Read moreCyprotex supply a range of services to assess the potential toxicity of chemicals including genotoxicity and phototoxicity screening methods..
Read moreCyprotex specializes in ADME-Tox and Biosciences. We work with a range of customers in the pharmaceutical, chemical, personal care and cosmetic industries.